Theme 4 In vivo experimental models

• Published in: Amyotrophic lateral sclerosis and frontotemporal degeneration 2019-11, Vol.20 (sup1), p.160-187
• Main Authors: Chudinova, Aleksandra V, Rossel, Mireille, Vergunst, Annette, Le-Masson, Gwendal, Camu, William, Raoul, Cédric, Lumbroso, Serge, Mouzat, Kevin
• Format: Article
• Language: English
• Subjects: Life Sciences
• ISSN: 2167-8421; 2167-9223
• DOI: 10.1080/21678421.2019.1646992

In 90% of Amyotrophic Lateral Sclerosis (ALS) cases, the disease is sporadic, the remaining 10% being familial. Many genes have been associated with the disease. The use of next generation sequencing has allowed increasing the number of genes analysed in routine diagnostics. However, this increase raises the issue of genetic variants interpretation within a growing number of ALS-associated-genes. Variant classification is based on a combinatory analysis of multiple factors. Among them, functional analyses provide strong arguments on pathogenicity interpretation. We developed a simple animal model, the Zebrafish, for the functional analysis of candidate variants pathogenicity identified by routine genetic testing. Transient overexpression of different ALS associated genetic variants has been performed by mRNA injection in 1-cell stage zebrafish eggs. Validation of protein overexpression has been done by western blot. Embryos mortality, developmental delay and morphological abnormalities have been assessed within the first two days of development. Cellular phenotype has been investigated by the analysis of axonal length of 2-days old larvae with confocal microscopy. Motor phenotype of 5-days old larvae has been explored by touched-evoked response assay. The model has been validated by the analysis of well-described ALS mutations, SOD1-Gly93Ala and OPTN Glu478Gly. Overexpression of this mutated protein was shown to provoke a shortening of axons and a premature axonal branching, as well as an impairment of motor performances as expected. We did not observe these aberrations in injected fishes. Two candidate variants observed in ALS-patients have been explored with our model: NM_000454.4:c.400_402del, p.Glu134del and NM_021980.4:c.1475T > G, p. Leu492Arg. Overexpression of both variants induced morphological abnormalities and motor impairment, suggesting a pathogenic involvement of these variants in ALS-patients. We developed for the first time a simple animal model, the Zebrafish, useful for the functional analysis of variant pathogenicity in order to assist ALS molecular diagnosis. Our model has been used to assess the pathogenicity of and candidate variants, allowing to improve genetic testing interpretation.